The most commonly reported adverse events (observed in less than 5% of clinical trial participants) were nausea, diarrhea, vomiting, constipation, abdominal pain, dyspepsia, injection-site reactions, fatigue, hypersensitivity reactions, eructation, hair loss, and gastroesophageal reflux disease The label for Zepbound includes a boxed warning regarding thyroid C-cell tumors
Reflux and regurgitation can cause more bad odour and erosion of the enamel, Ouanounou said
This glucagon-like peptide-1 (GLP-1) receptor agonist is the active ingredient in Wegovy, Rybelsus, and Ozempicthe last of which has become a household name after countless celebrities spread the word that it helped them lose weight
For employer-sponsored self-insured plans, you may also have the option to request an independent external review
Incidence rates for the 4 outcomes were elevated among GLP-1 agonists compared with bupropion-naltrexone users (Table 1)